Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Qilian International Holding Group Limited Receives Approval for the Sale of its Newly Developed Nitrofurantoin Enteric-coated Tablets 2022-01-19 20:30
Eluminex Biosciences Acquires Zuretinol Acetate from Retinagenix Holdings 2022-01-19 19:49
Accomplished Pharma R&D leader, Sauri Gudlavalleti joins Sai Life Sciences as Chief Operating Officer 2022-01-19 18:30
Novotech Completes $255M Private Placement Transaction and $505M Refinancing to Accelerate Implementation of Growth Initiatives 2022-01-19 16:38
XtalPi Partners with Excelra for GOSTAR to Enhance its Intelligent Digital Drug Discovery and Development platform 2022-01-19 09:00
ImmVira's MVR-T3011 IV completed first 2 cohorts dose-escalation of U.S. Phase I clinical study with favorable safety data 2022-01-19 08:30
CN Energy Signs Operation & Management Agreement; Enters Multi-Billion Dollar Pharmaceutical Excipients Market 2022-01-18 21:00
Akeso's AK117 (CD47 monoclonal antibody) in Combination with AK112 (PD-1/VEGF bi-specific antibody) to Initiate a Phase Ib/II Clinical Trial with or without Chemotherapy for the Treatment of Advanced Malignant Tumors 2022-01-18 20:44
Servier Group Reports Financial Year 2020/2021 Annual Results, R&D Strategy and Pipeline 2022-01-18 20:00
MindRank Begins IND-enabling Studies of its first AI-designed Drug, 8 Months After Program Initiation 2022-01-18 17:17
e-BEAUTY LAUNCHES DNA TEST KITS FOR ASIANS 2022-01-18 16:09
Genetech Biotechnology Launches Four Exclusive Promo Bundles For Citrea In Celebration Of Chinese New Year 2022-01-18 15:16
WuXi Biologics Completes GMP Inspection by South Korea's Ministry of Food and Drug Safety for Drug Substance Facility 2022-01-18 10:50
Abbisko Therapeutics Announces Worldwide Collaboration with Lilly to Discover and Develop Novel Molecules 2022-01-18 10:41
Sciwind Biosciences Announces Initiation of Patient Dosing in Phase 2b Clinical Trial Evaluating XW003, its Lead GLP-1 Drug Candidate, for the Treatment of Obesity 2022-01-18 08:00
CStone announced two key phase 3 registrational clinical trials of sugemalimab completed patient enrollment 2022-01-18 08:00
CARsgen Appoints Richard John Daly as the President of CARsgen Therapeutics Corporation 2022-01-17 21:50
Seegene Continues to Support Israel's Effort to Manage the Omicron Variant With Timely Delivery of Five Million Tests 2022-01-17 20:00
HTPE Leads JYSSBIO to Close Series B+ Funding 2022-01-17 17:58
The Philippines Has Approved ReCOV For Phase II/III Cinical Trial 2022-01-17 16:57
1 197 198 199 200 201 452